Clinical Trial Update: Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing telavancin with vancomycin for complicated skin and skin structure infections, including MRSA, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections
• Methicillin-resistant Staphylococcus Aureus Infection
• Staphylococcus Aureus Infection

Drugs mentioned

• Vancomycin (vancomycin)
• Vibativ (telavancin)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Staphylococcal Skin Infection | Phase 3 | Status: COMPLETED | Results posted: 2009-12-08